Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Chronic Hepatitis B Patients [Phase 2]

View source ↗

Summary

A multicenter Phase II randomized trial evaluating TVAX-008 injection for chronic Hepatitis B (HBV infection) is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TVAX-008

Snippet

Sponsor: Grand Theravac Life Sciences (Nanjing) Co., Ltd. | Conditions: HBV Infection | Phase 2 | Status: ACTIVE_NOT_RECRUITING